Proteostasis Therapeutics (PTI) Announces Emmanuel Dulac and Kim Drapkin to Board
Tweet Send to a Friend
Proteostasis Therapeutics, Inc. (NASDAQ: PTI) today announced that Emmanuel Dulac, PharmD, Ph.D., and Kim Cobleigh Drapkin, CPA, have been appointed ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
